Document is current
Any future updates will be listed below
-
Authors
Shimizu, Megumi
Miyazaki, Tetsuro
Takagi, Atsutoshi
Sugita, Yurina
Ouchi, Shohei
Aikawa, Tatsuro
Shiozawa, Tomoyuki
Hiki, Masaru
Takahashi, Shuhei
Hiki, Makoto
Shimada, Kazunori
Daida, Hiroyuki
-
Funding
Funding for this research was provided by:
JSPS KAKENHI (JP15K00845, JP16K00869)
- License Information
-
More Information
Article History
Received: 6 January 2020
Accepted: 4 September 2020
First Online: 16 September 2020
Compliance with ethical standards
:
: Dr. Daida has received remuneration for lectures from Amgen Astellas Biopharma K.K., Astellas Pharma Inc., AstraZeneca Pharma Ltd., GlaxoSmithKline K.K., Sanofi K.K., Shionogi Daiichi-Sankyo Pharmaceutical Company Ltd., Takeda Pharmaceutical Company Ltd., Terumo Corporation, Medtronic plc., Boehringer Ingelheim GmbH., Bayer AG., and MSD K.K., trust research and joint research funds from Kowa Pharmaceutical Company Ltd., Daiichi-Sankyo Company Ltd., Canon Medical Systems Corporation, Nihon Medi-Physics Company Ltd., Kaken Pharmaceutical Company Ltd., Kirin Holdings Company Ltd., Philips Respironics Ltd., Sanwa Kagaku Kenkyusho Company Ltd., and St. Jude Medical Japan Company Ltd., and scholarship fund from Astellas Pharma Inc., Abbott Laboratories, Otsuka Pharmaceutical Company Ltd., Sanofi K.K., Shionogi & Company Ltd., Sumitomo Dainippon Pharmaceutical Company Ltd., Boehringer Ingelheim GmbH., Bayer AG., Teijin Ltd., Daiichi-Sankyo Company Ltd., Takeda Pharmaceutical Company Ltd., MSD K.K., Tanabe Mitsubishi Pfizer Pharmaceutical Company Ltd., Philips Respironics Ltd., Bristol-Myers Squibb Company Ltd., Boston Scientific Ltd., St. Jude Medical Japan Company Ltd., and Actelion Pharmaceuticals Japan Ltd.. He has been in affiliation with some endowed departments including VitalAire Japan Company K.K., Philips Respironics Ltd., Fukuda Denshi Company Ltd., ResMed Ltd.. The remaining authors report no conflict of interest.
